SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Borrego, D.M. Farrington, F.J. Downey, Advances in bone dysplasias, Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2014, 58, 3, 171

    CrossRef

  2. 2
    Marina B. Zambrano, Evelise S. Brizola, Lilia Refosco, Roberto Giugliani, Têmis M. Félix, Anthropometry, Nutritional Status, and Dietary Intake in Pediatric Patients with Osteogenesis Imperfecta, Journal of the American College of Nutrition, 2014, 33, 1, 18

    CrossRef

  3. 3
    Alison M. Boyce, Laura L. Tosi, Scott M. Paul, Bisphosphonate Treatment for Children With Disabling Conditions, PM&R, 2014, 6, 5, 427

    CrossRef

  4. 4
    E. Borrego, D.M. Farrington, F.J. Downey, Novedades en displasias óseas, Revista Española de Cirugía Ortopédica y Traumatología, 2014, 58, 3, 171

    CrossRef

  5. 5
    John Hellstein, Osteochemonecrosis: An Overview, Head and Neck Pathology, 2014, 8, 4, 482

    CrossRef

  6. 6
    Stefano Stagi, Loredana Cavalli, Salvatore Seminara, Maurizio de Martino, Maria Brandi, The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment, Italian Journal of Pediatrics, 2014, 40, 1, 55

    CrossRef

  7. 7
    K. Lindahl, B. Langdahl, O. Ljunggren, A. Kindmark, THERAPY OF ENDOCRINE DISEASE: Treatment of osteogenesis imperfecta in adults, European Journal of Endocrinology, 2014, 171, 2, R79

    CrossRef

  8. 8
    Raoul H.H. Engelbert, Marco van Brussel, Eugene Rameckers, Osteogenesis Imperfecta, 2014,

    CrossRef

  9. 9
    Dominique Laron, Nirav K. Pandya, Advances in the Orthopedic Management of Osteogenesis Imperfecta, Orthopedic Clinics of North America, 2013, 44, 4, 565

    CrossRef

  10. 10
    Dieke H J Kok, Ralph J B Sakkers, Hans E H Pruijs, Pieter Joosse, René M Castelein, Bone mineral density in developing children with osteogenesis imperfecta, Acta Orthopaedica, 2013, 84, 4, 431

    CrossRef

  11. 11
    Outi Mäkitie, Causes, mechanisms and management of paediatric osteoporosis, Nature Reviews Rheumatology, 2013, 9, 8, 465

    CrossRef

  12. 12
    Ross Drake, Brian J. Anderson, John N. Anker, Boris Zernikow, Managing persisting pain in children with medical illnesses: another frontier unexplored, Pediatric Anesthesia, 2013, 23, 5
  13. 13
    Jay R Shapiro, Caressa Lietman, Monica Grover, James T Lu, Sandesh CS Nagamani, Brian C Dawson, Dustin M Baldridge, Matthew N Bainbridge, Dan H Cohn, Maria Blazo, Timothy T Roberts, Feng-Shu Brennen, Yimei Wu, Richard A Gibbs, Pamela Melvin, Philippe M Campeau, Brendan H Lee, Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM5 Mutation, Journal of Bone and Mineral Research, 2013, 28, 7
  14. 14
    Vivian Bradaschia-Correa, Mariana M. Moreira, Victor E. Arana-Chavez, Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats, Cell and Tissue Research, 2013, 353, 1, 79

    CrossRef

  15. 15
    Maximilien Vanleene, Sandra J. Shefelbine, Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone, Bone, 2013, 53, 2, 507

    CrossRef

  16. 16
    Jay R. Shapiro, Osteoporosis, 2013,

    CrossRef

  17. 17
    Hiroyuki Tanaka, Bisphosphonate treatment in osteogenesis imperfecta, Okayama Igakkai Zasshi (Journal of Okayama Medical Association), 2012, 124, 1, 67

    CrossRef

  18. 18
    N. Nicolaou, Y. Agrawal, M. Padman, J. A. Fernandes, M. J. Bell, Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates, Journal of Children's Orthopaedics, 2012, 6, 1, 21

    CrossRef

  19. 19
    Sanjay K. Chilbule, Vrisha Madhuri, Complications of pamidronate therapy in paediatric osteoporosis, Journal of Children's Orthopaedics, 2012, 6, 1, 37

    CrossRef

  20. 20
    John P. Lubicky, The Spine in Osteogenesis Imperfecta, Spine Deformity, 2012,

    CrossRef

  21. 21
    Oral Pathology, 2012,

    CrossRef

  22. 22
    M. Salom, S. Vidal, L. Miranda, Aplicaciones de los bifosfonatos en la ortopedia infantil, Revista Española de Cirugía Ortopédica y Traumatología, 2011, 55, 4, 302

    CrossRef

  23. 23
    M. Salom, S. Vidal, L. Miranda, Bisphosphonate applications in children's orthopaedics, Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2011, 55, 4, 302

    CrossRef

  24. 24
    Taichi Kitaoka, Noriyuki Namba, Kohji Miura, Takuo Kubota, Yasuhisa Ohata, Makoto Fujiwara, Haruhiko Hirai, Takehisa Yamamoto, Keiichi Ozono, Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta, Journal of Bone and Mineral Metabolism, 2011, 29, 5, 598

    CrossRef

  25. 25
    Séverine Battaglia, Sophie Dumoucel, Julie Chesneau, Marie-Françoise Heymann, Gaëlle Picarda, François Gouin, Nadège Corradini, Dominique Heymann, Françoise Redini, Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient, Journal of Bone and Mineral Research, 2011, 26, 10
  26. 26
    Antonella Forlino, Wayne A. Cabral, Aileen M. Barnes, Joan C. Marini, New perspectives on osteogenesis imperfecta, Nature Reviews Endocrinology, 2011, 7, 9, 540

    CrossRef

  27. 27
    Aaron L. Zuckerberg, Myron Yaster, Smith's Anesthesia for Infants and Children, 2011,

    CrossRef

  28. 28
    Toru Hiraga, Tadashi Ninomiya, Akihiro Hosoya, Hiroaki Nakamura, Administration of the Bisphosphonate Zoledronic Acid During Tooth Development Inhibits Tooth Eruption and Formation and Induces Dental Abnormalities in Rats, Calcified Tissue International, 2010, 86, 6, 502

    CrossRef

  29. 29
    E Åström, P Magnusson, S Eksborg, S Söderhäll, Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta, Acta Paediatrica, 2010, 99, 12
  30. 30
    Jay R. Shapiro, Carol B. Thompson, Yimei Wu, Martin Nunes, Carolynn Gillen, Bone Mineral Density and Fracture Rate in Response to Intravenous and Oral Bisphosphonates in Adult Osteogenesis Imperfecta, Calcified Tissue International, 2010, 87, 2, 120

    CrossRef

  31. 31
    F. Antoniazzi, E. Monti, G. Venturi, R. Franceschi, F. Doro, D. Gatti, G. Zamboni, L. Tato, GH in combination with bisphosphonate treatment in osteogenesis imperfecta, European Journal of Endocrinology, 2010, 163, 3, 479

    CrossRef

  32. 32
    V. Fano, M. Rodríguez Celin, M. del Pino, S. Buceta, M.G. Obregón, C. Primomo, H. García, H. Miscione, H. Lejarraga, Osteogénesis imperfecta. Evaluación clínica, funcional y multidisciplinaria de 65 pacientes, Anales de Pediatría, 2010, 72, 5, 324

    CrossRef

  33. 33
    Jay R. Shapiro, Osteoporosis in Men, 2010,

    CrossRef

  34. 34
    Serge Ferrari, Ego Seeman, Hong-Wen Deng, David G Little, Toshio Matsumoto, Clinical and basic research papers – February 2009, IBMS BoneKEy, 2009, 6, 2, 44

    CrossRef

  35. 35
    Jay R Shapiro, Paul D Sponsellor, Osteogenesis imperfecta: questions and answers, Current Opinion in Pediatrics, 2009, 21, 6, 709

    CrossRef

  36. 36
    Leanne M Ward, Anna Petryk, Catherine M Gordon, Use of bisphosphonates in the treatment of pediatric osteoporosis, International Journal of Clinical Rheumatology, 2009, 4, 6, 657

    CrossRef

  37. 37
    Kerry Dwan, Carrie A Phillipi, Robert D Steiner, Donald Basel, Bisphosphonate therapy for osteogenesis imperfecta, The Cochrane Library,